This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Nature Communications Open Access 01 February 2023
SuperFi-Cas9 exhibits remarkable fidelity but severely reduced activity yet works effectively with ABE8e
Nature Communications Open Access 11 November 2022
Nature Communications Open Access 24 September 2022
Subscribe to Journal
Get full journal access for 1 year
only $8.25 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819–823 (2013).
Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823–826 (2013).
Konermann, S. et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 10.1038/nature14136 (10 December 2014).
Gilbert, L.A. et al. Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159, 647–661 (2014).
Qi, L.S. et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152, 1173–1183 (2013).
Nishimasu, H. et al. Crystal structure of cas9 in complex with guide RNA and target DNA. Cell 156, 935–949 (2014).
Banaszynski, L.A., Liu, C.W. & Wandless, T.J. Characterization of the FKBP·rapamycin·FRB ternary complex. J. Am. Chem. Soc. 127, 4715–4721 (2005).
Konermann, S. et al. Optical control of mammalian endogenous transcription and epigenetic states. Nature 500, 472–476 (2013).
Hsu, P.D. et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31, 827–832 (2013).
Fu, Y., Sander, J.D., Reyon, D., Cascio, V.M. & Joung, J.K. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat. Biotechnol. 32, 279–284 (2014).
Perez-Pinera, P. et al. RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat. Methods 10, 973–976 (2013).
We would like to thank N.E. Sanjana, S. Konermann, M.D. Brigham, A. Trevino, F.A. Ran and W. Yan for technical assistance, S. Jones, M. Heidenreich and K. Zheng for editing and members of the Zhang laboratory for discussion, support and advice. F.Z. is supported by the National Institute of Mental Health (NIMH) through a National Institutes of Health (NIH) Director's Pioneer Award (DP1-MH100706), the National Institute of Neurological Disorders and Stroke (NINDS) through an NIH Transformative R01 grant (R01-NS 07312401), National Science Foundation (NSF) Waterman Award, the Keck, Damon Runyon, Searle Scholars, Klingenstein, Vallee, Merkin and Simons Foundations, and Bob Metcalfe, New York Stem Cell Foundation. F.Z. is a New York Stem Cell Foundation Robertson Investigator. CRISPR reagents are available to the academic community through Addgene, and associated protocols, support forum and computational tools are available via the Zhang laboratory website (http://www.genome-engineering.org).
Feng Zhang is a scientific advisor of Editas Medicine and of Horizon Discovery.
About this article
Cite this article
Zetsche, B., Volz, S. & Zhang, F. A split-Cas9 architecture for inducible genome editing and transcription modulation. Nat Biotechnol 33, 139–142 (2015). https://doi.org/10.1038/nbt.3149
This article is cited by
Nature Communications (2023)
Parasites & Vectors (2022)
A splitCas9 phenotypic screen in Toxoplasma gondii identifies proteins involved in host cell egress and invasion
Nature Microbiology (2022)
Nature Protocols (2022)
Nature Communications (2022)